It is a myth that Cancer is prevalent only in urban areas More than 5,56,000 Cancer deaths occurred in India in 2010 and 71.1 per cent of those who died were aged between 30 and 69 years, says a report on Cancer mortality in India, published in the March 28 issue of The Lancet. While men in the age group of 30-69 years are more likely to die of oral Cancers followed...
More »SEARCH RESULT
Tobacco-related Cancers, cervical Cancer cause most deaths in India by R Prasad
A new study looking at Cancer mortality in 2010 in India found a high 71 per cent (3,95,400) deaths in people between 30 and 69 years. Cancer accounted for 8 per cent of the 2·5 million total male deaths and 12 per cent of the 1·6 million total female deaths in the same age group. The high mortality rate during the middle age is very different from the developed countries,...
More »Cancer killed 5.3 lakh in India in 2011-Kounteya Sinha
Tata Memorial Hospital, Lancet, Centre for Global Health Research and University of Toronto jointly releases study findings on Cancer mortality in India in 2010. The findings are: There were 5.56 lakh Cancer deaths in India in 2010. 71% (3.95 lakhs) of these deaths occurred in people aged 30-69 years (2 lakh men and 1.95 lakh women). Cancer deaths accounted for 6% of deaths across all ages, but among the 30-69 years age group, this...
More »A Strike against Pharma MNCs
-Economic and Political Weekly The compulsory licence for Nexavar is only the beginning of a new battle over drug prices. The grant of a compulsory licence (CL) to Natco Pharma, a relatively small Indian pharmaceutical company, to manufacture and sell the Cancer drug sorafenib (Nexavar) has been rightly hailed as a major step forward for public health and the wider availability of life saving medicines. The German pharmaceutical company Bayer holds the patent...
More »Drug trials: Irked NHRC issues notices to Centre and Andhra Pradesh government-M Suchitra
Says respond else face action Annoyed by the non-submission of reports regarding illegal clinical trials of breast Cancer drug, the National Human Rights Commission (NHRC) has issued notices to the Union health ministry and the Andhra Pradesh government. It has asked the Centre and the state government to respond within six weeks or face action. The commission had in June last year sent notices to the Union health secretary, secretary of the...
More »